#Sources chinabased keep linkdoc us ipotimes software
#Sources chinabased keep linkdoc us ipotimes series

#Sources chinabased keep linkdoc us ipotimes series

LinkDoc just received a strategic investment from Alibaba Health on March 4 and secured 700 million yuan in the series D+ financing round led by CICC Capital last year. Last year, Burning Rock Biotech Ltd and Genetron Health, two leading companies in China's tumor genetic testing industry, also went public on Nasdaq.

Its services are used in hospitals, clinics, pharmaceutical companies, and government administrations, which include the Chinese Medical Doctor Association, and the China Society of Clinical Oncology, among others.Ĭontext: Since the outbreak of the pandemic, the biotechnology sector represented by precision medicine has become a highly sought-after industry in the secondary market. LinkDoc did not immediately respond to a request for comment. The sources declined to be identified as the information has not yet been made public.

The book closed one day earlier than planned on Wednesday, one of the three sources and a separate person said. LinkDoc’s revenue increased by 40.8% from 158.5 million yuan for the three months ended March 31, 2020, to 223.2 million yuan ($34.1 million) for the three months ended March 31, 2021.įounded in 2014 in Beijing by Shan He and Tony Zhang, LinkDoc offers a repository of big data for the healthcare industry such as clinical trials, AI diagnosis, and management. It had planned to sell 10.8 million shares between 17.50 and 19.50 each. Citing sources, Bloomberg reported last month that LinkDoc was eying to raise $500 million in IPO. Being conscientious with our customer data is a responsibility that we take very seriously. That’s why we would like to notify you of updates to our privacy policy in preparation for the new data protection law. It is essential to everyone at QI Sourcing to keep any personal data safe and secure. The company said the proceeds of the IPO will be used to strengthen its research and development capabilities, investment, and acquisitions. Our customer’s privacy is important to us. LinkDoc Technology Ltd, a medical data company backed by Alibaba's health subsidiary, filed for an initial public offering in the US on Monday.ĭetails: In the F-1 filling submitted to the US Securities and Exchange Commission, the company stated that it plans to list its American depositary shares on Nasdaq under the symbol 'LDOC'. We make it easier to manage your sales team and marketing campaigns while also increasing efficiency and production, with proven methods.

#Sources chinabased keep linkdoc us ipotimes software

The sources declined to be named as the information has not yet been made public yet.īeijing-based LinkDoc did not immediately respond to a request for comment.Alibaba-backed medical data company LinkDoc files for US IPO - PingWest English 中文Īlibaba-backed medical data company LinkDoc files for US IPO J2:28 am eMaximation's lead management and marketing automation software allows companies to grow their business by easily capturing, contacting, qualifying, and converting more leads into sales.

The book closed one day earlier than planned on Wednesday, two of the sources said. The deal would have raised $211 million at the upper end of the indicated range. It had planned to sell 10.8 million shares between $17.50 and $19.50 each.

LinkDoc filed for an initial public offering in the United States last month and was due to price its shares after the U.S. One of the sources said the regulatory uncertainty affected both the company and investors. The decision to pull the LinkDoc deal was due to the crackdown, the sources said. It is the first known Chinese firm to pull back from its IPO plans since the crackdown began last week with an investigation by China's cybersecurity regulator into ride-hailing giant Didi Global Inc just two days after it made its New York debut.īeijing said on Tuesday that it would strengthen supervision of all Chinese firms listed offshore, a sweeping regulatory shift that triggered a sell-off in U.S.-listed Chinese stocks. Live news, investigations, opinion, photos and video by the journalists of The New York Times from more than 150 countries around the world. HONG KONG - Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States following Beijing's clampdown on overseas listings by domestic firms, according to three sources with direct knowledge of the matter. HONG KONG (Reuters) Chinese medical data group LinkDoc Technology Ltd has shelved its listing in the United States to raise up to 211 million following Beijing’s clampdown on overseas listings, according to three sources with direct knowledge of the matter.